AD-32
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AD-32, covering 2013-01-31 to 2013-01-31. Get the full timeline:
Most recent: Clinical Trial Update: AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer [Phase 2]